Article

Management of ocular inflammation and pain using novel insert

Author(s):

Julianne Mobilian
Conferences|ASCRS

ICMYI: Dr. Tyson shares his pearls using the dexamethasone 0.4 mg insert (Dextenza, Ocular Therapeutix).

Sydney Tyson, MD, shares the take-home message from the presentation he delivered at the 2019 American Society of Cataract and Refractive Surgery meeting: "Management of Ocular Inflammation and Pain Following Cataract Surgery with Dexamethasone 0.4 mg Insert (Dextenza, Ocular Therapeutix)."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
At the 2025 American Society of Cataract and Refractive Surgery (ASCRS) meeting, Seth Pantanelli, MD, speaks about the EyHance and enVista IOLs. Dr. Pantanelli is a professor of ophthalmology at Penn State College of Medicine in Hershey, Pennsylvania.
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
Related Content
Resident surgeons perform ISBCS with similar safety and accuracy as consultants
June 13th 2025

Resident surgeons perform ISBCS with similar safety and accuracy as consultants

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Ophthalmologists present data on perfluorohexyloctane eye drops
June 6th 2025

Ophthalmologists present data on perfluorohexyloctane eye drops

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
December 19th 2023

EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery

Left: Dr. Maloney in 1998 outside the laser suite at the newly opened Maloney Vision Institute. Right: Dr. Maloney's final symposium talk in May 2025, Los Angeles. Images courtesy Robert Maloney.
May 29th 2025

Robert Maloney, MD, announces retirement from clinical practice

(Image credit: AdobeStock/frender) Q&A: Brandon D. Ayres, MD, on streamlining anterior vitrectomy with a high-speed, small-gauge probe at ASCRS 2025
May 26th 2025

Q&A: Brandon D. Ayres, MD, on streamlining anterior vitrectomy with a high-speed, small-gauge probe at ASCRS 2025

© 2025 MJH Life Sciences

All rights reserved.